2011•Medical InformationRequires access

Effectivenss and Pharmacoeconmic Analysis of Gatifloxacin and Levofloxacin in the Treatment of Urinary Sytem Infection

HE Jin-hong

Open publisher page 0 citations

Abstract

Objective To compare the cost-effectiveness ratio of gatifloxacin and levofloxacin in the treatment of patints with infection in urinary system.Methods Principle of pharmaconomics wsa adopted to analyze the cost-effectiveness of two trestment schemes.Results The effective rates of gatifloxacin group and ievoflosacin group in the treatment of urinary system intection were 92.86% and 88.46%(P0.05) respectively;the incidence rates of adverse reacrions were 7.1% and 9.0%(P0.05);The cost-effectiveness rauos(C/E) were 7.99 and 6.53 respectively.The cost for every one unit increment of effectiveness tor gatifloxacin group was 37.43 Yuan more than that of the levofloxacin group.Conclusion The cost-effectiveness ratio of levotloxccin is superior to that of gatifloxacin in treatment of urinary system infection.

About this research paper

What this paper is about

Objective To compare the cost-effectiveness ratio of gatifloxacin and levofloxacin in the treatment of patints with infection in urinary system.Methods Principle of pharmaconomics wsa adopted to analyze the cost-effectiveness of two trestment schemes.Results The effective rates of gatifloxacin group and ievoflosacin group in the treatment of urinary system intection were 92.86% and 88.46%(P0.05) respectively;the incidence rates of adverse reacrions were 7.1% and 9.0%(P0.05);The cost-effectiveness rauos(C/E) were 7.99 and 6.53 respectively.The cost for every one unit increment of effectiveness tor gatifloxacin group was 37.43 Yuan more than that of the levofloxacin group.Conclusion The cost-effectiveness ratio of levotloxccin is superior to that of gatifloxacin in treatment of urinary system infection.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the cost-effectiveness ratio of gatifloxacin and levofloxacin in the treatment of patints with infection in urinary system.Methods Principle of pharmaconomics wsa adopted to analyze the cost-effectiveness of two trestment schemes.Results The effective rates of gatifloxacin group and ievoflosacin group in the treatment of urinary system intection were 92.86% and 88.46%(P0.05) respectively;the incidence rates of adverse reacrions were 7.1% and 9.0%(P0.05);The cost-effectiveness rauos(C/E) were 7.99 and 6.53 respectively.The cost for every one unit increment of effectiveness tor gatifloxacin group was 37.43 Yuan more than that of the levofloxacin group.Conclusion The cost-effectiveness ratio of levotloxccin is superior to that of gatifloxacin in treatment of urinary system infection.

Key concepts: Gatifloxacin, Levofloxacin, Medicine, Urinary system, Incidence (geometry), Internal medicine, Urology, Microbiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effectivenss and Pharmacoeconmic Analysis of Gatifloxacin and Levofloxacin in the Treatment of Urinary Sytem Infection — Research Paper | ScholarLens